MedMira Partners with Trimedic for Canadian Market Expansion

MedMira Inc. has announced an exclusive distribution agreement with Trimedic Inc. for Canada. This partnership aims to expand MedMira's presence in the Canadian market with their recently Health Canada approved rapid antibody tests: Multiplo® TP/HIV and Reveal® G4 HIV-1/2. These products have received Class 4 Medical Device Licenses, the highest regulatory classification in Canada.

Trimedic Inc., a prominent Canadian medical supplies distributor, focuses on delivering laboratory-quality tests at point-of-care locations, reducing wait times for critical health results. This agreement aligns with Trimedic’s strategy to decentralize diagnostic testing.

HIV cases in Canada have increased significantly, creating a demand for effective testing solutions. The new partnership is set to address this need, particularly in underserved regions, offering essential testing devices for HIV and syphilis.